{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:41:54Z","timestamp":1789123314107,"version":"build-2803163510"},"reference-count":164,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health","award":["AM19606"],"award-info":[{"award-number":["AM19606"]}]}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["IJMS"],"abstract":"<jats:p>Systemic Sclerosis (SSc) is a systemic autoimmune disease of unknown etiology characterized by a severe fibroproliferative vasculopathy and frequently progressive cutaneous and internal organ fibrosis. The small-vessel vasculopathy and the tissue fibrotic alterations are responsible for the most serious clinical and pathological manifestations of the disease and for its high mortality. Despite the high severity and frequent mortality, there are currently no optimal therapeutic approaches for SSc, and its complex pathogenesis has not been fully elucidated. Numerous studies have suggested that growth factors and related regulatory macromolecules released from inflammatory and other cells present in the affected tissues play a crucial role in the frequently progressive cutaneous and visceral fibrosis. Here, we will review some of the recent studies describing the role of various growth factors and related macromolecules in the development and progression of the fibrotic process in SSc.<\/jats:p>","DOI":"10.3390\/ijms26199596","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:06:02Z","timestamp":1759316762000},"page":"9596","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Role of Growth Factors in the Pathogenesis of Systemic-Sclerosis-Associated Fibrosis"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3901-5771","authenticated-orcid":false,"given":"Fabian A.","family":"Mendoza","sequence":"first","affiliation":[{"name":"Jefferson Institute of Molecular Medicine, and Scleroderma Center; Thomas Jefferson University, Philadelphia, PA 19107, USA"},{"name":"Division of Rheumatology, Department of Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonsoles","family":"Piera-Velazquez","sequence":"additional","affiliation":[{"name":"Jefferson Institute of Molecular Medicine, and Scleroderma Center; Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A.","family":"Jimenez","sequence":"additional","affiliation":[{"name":"Jefferson Institute of Molecular Medicine, and Scleroderma Center; Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12016-022-08929-x","article-title":"A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis","volume":"64","author":"Lazzaroni","year":"2023","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-140-1-200401060-00010","article-title":"Following the molecular pathways toward an understanding of the pathogenesis of Systemic Sclerosis","volume":"140","author":"Jimenez","year":"2004","journal-title":"Ann. Int. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/BOR.0b013e3282e6f495","article-title":"Molecular pathways as novel therapeutic targets in systemic sclerosis","volume":"19","author":"Trojanowska","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5301\/jsrd.5000249","article-title":"Pathogenesis of systemic sclerosis: Recent insights of molecular and cellular mechanisms and therapeutic opportunities","volume":"2","author":"Varga","year":"2017","journal-title":"J. Scleroderma Relat. Disord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","article-title":"Pathophysiology of systemic sclerosis: Current understanding and new insights","volume":"15","author":"Cutolo","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12016-021-08889-8","article-title":"Current Concepts on the Pathogenesis of Systemic Sclerosis","volume":"64","author":"Truchetet","year":"2023","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.mehy.2006.07.053","article-title":"Does transformation of microvascular endothelial cells into myofibroblasts play a key role in the etiology and pathology of fibrotic disease?","volume":"68","author":"Karasek","year":"2007","journal-title":"Med. Hypotheses"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/ar2188","article-title":"Fibrosis in connective tissue disease: The role of the myofibroblast and fibroblast-epithelial cell interactions","volume":"9","author":"Krieg","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.bor.0000139310.77347.9c","article-title":"Cellular origins of fibroblasts: Possible implications for organ fibrosis in systemic sclerosis","volume":"16","author":"Postlethwaite","year":"2004","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.rdc.2007.11.002","article-title":"Fibrosis in systemic sclerosis","volume":"34","author":"Varga","year":"2008","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.autrev.2010.09.015","article-title":"Fibrosis in systemic sclerosis: Emerging concepts and implications for targeted therapy","volume":"10","author":"Wei","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/BOR.0000000000000217","article-title":"Origin of fibrosing cells in systemic sclerosis","volume":"27","author":"Ebmeier","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Jimenez, S.A., and Piera-Velazquez, S. (2023). Cellular Transdifferentiation: A Crucial Mechanism of Fibrosis in Systemic Sclerosis. Curr. Rheumatol. Rev., Epub ahead of print.","DOI":"10.2174\/0115733971261932231025045400"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","article-title":"The myofibroblast: One function, multiple origins","volume":"170","author":"Hinz","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.biocel.2006.11.005","article-title":"Fibroblasts and myofibroblasts: Their source, function and role in disease","volume":"39","author":"McAnulty","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41584-019-0324-5","article-title":"Evasion of apoptosis by myofibroblasts: A hallmark of fibrotic diseases","volume":"16","author":"Hinz","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1074\/jbc.270.7.3423","article-title":"Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1","volume":"270","author":"Kirk","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11926-007-0008-z","article-title":"New developments in fibroblast and myofibroblast biology: Implications for fibrosis and scleroderma","volume":"9","author":"Abraham","year":"2007","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/BOR.0000000000000543","article-title":"Insights into myofibroblasts and their activation in scleroderma: Opportunities for therapy?","volume":"30","author":"Abraham","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Chadli, L., Sotthewes, B., Li, K., Andersen, S.N., Cahir-McFarland, E., Cheung, M., Cullen, P., Dorj\u00e9e, A., de Vries-Bouwstra, J.-K., and Huizinga, T.W.J. (2019). Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-41153-w"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/BOR.0000000000000903","article-title":"Insights into molecular and clinical characteristics of very early systemic sclerosis","volume":"34","year":"2022","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: From mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","article-title":"Shared and distinct mechanisms of fibrosis","volume":"15","author":"Distler","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"101191","DOI":"10.1016\/j.mam.2023.101191","article-title":"Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies","volume":"92","author":"Lurje","year":"2023","journal-title":"Mol. Asp. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101252","DOI":"10.1016\/j.mam.2024.101252","article-title":"Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis","volume":"96","author":"Abraham","year":"2024","journal-title":"Mol. Asp. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/157339710793205611","article-title":"Role of Growth factors in the pathogenesis of tissue fibrosis in Systemic Sclerosis","volume":"6","author":"Jimenez","year":"2010","journal-title":"Curr. Rheumatol. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e20190103","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor\u2013\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2741\/s22","article-title":"Transforming growth factor-beta in systemic sclerosis (scleroderma)","volume":"1","author":"Varga","year":"2009","journal-title":"Front. Biosci. (Schol. Ed)"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","article-title":"Transforming growth factor \u03b2\u2014At the centre of systemic sclerosis","volume":"10","author":"Lafyatis","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcdb.2019.12.010","article-title":"TGF-\u03b21-a truly transforming growth factor in fibrosis and immunity","volume":"101","author":"Lodyga","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_34","first-page":"471","article-title":"Transforming growth factor beta isoforms and TGF-\u03b2R1 and TGF-\u03b2R2 expression in systemic sclerosis patients","volume":"23","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.medj.2023.12.011","article-title":"Isoform-selective TGF-\u03b23 inhibition for systemic sclerosis","volume":"5","author":"Sun","year":"2024","journal-title":"Med"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Danielpour, D. (2024). Advances and Challenges in Targeting TGF-\u03b2 Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective. Pharmaceuticals, 17.","DOI":"10.3390\/ph17040533"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"16984","DOI":"10.1016\/S0021-9258(18)37487-8","article-title":"The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptor","volume":"263","author":"Cheifetz","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1074\/jbc.R400029200","article-title":"Latent transforming growth factor-beta (TGF-beta) binding proteins: Orchestrators of TGF-beta availability","volume":"280","author":"Rifkin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature10152","article-title":"Latent TGF-\u03b2 structure and activation","volume":"474","author":"Shi","year":"2011","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Verma, B.K., Chatterjee, A., Kondaiah, P., and Gundiah, N. (2023). Substrate Stiffness Modulates TGF-\u03b2 Activation and ECM-Associated Gene Expression in Fibroblasts. Bioengineering, 10.","DOI":"10.3390\/bioengineering10090998"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/emboj\/21.7.1743","article-title":"Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors","volume":"21","author":"Goumans","year":"2002","journal-title":"EMBO J."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Morikawa, M., Derynck, R., and Miyazono, K. (2016). TGF-beta and the TGF-beta Family: Context-Dependent Roles in Cell and Tissue Physiology. Cold Spring Harb. Perspect. Biol., 8.","DOI":"10.1101\/cshperspect.a021873"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1097-2765(03)00386-1","article-title":"Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta\/ALK5 signaling","volume":"12","author":"Goumans","year":"2003","journal-title":"Mol. Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cbin.12097","article-title":"Multifaceted TGF-\u03b2 signaling, a master regulator: From bench-to-bedside, intricacies, and complexities","volume":"48","author":"Ahuja","year":"2024","journal-title":"Cell Biol. Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.tcb.2017.04.005","article-title":"Transforming Growth Factor-\u03b2 Receptors and Smads: Regulatory Complexity and Functional Versatility","volume":"27","author":"Budi","year":"2017","journal-title":"Trends Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cellsig.2018.09.002","article-title":"TGF-\u03b2 receptors: In and beyond TGF-\u03b2 signaling","volume":"52","author":"Cao","year":"2018","journal-title":"Cell Signal."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1073\/pnas.83.12.4167","article-title":"Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro","volume":"83","author":"Roberts","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/bj2470597","article-title":"Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts","volume":"247","author":"Varga","year":"1987","journal-title":"Biochem. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/art.10413","article-title":"Scleroderma and Smads: Dysfunctional Smad family dynamics culminating in fibrosis","volume":"46","author":"Varga","year":"2002","journal-title":"Arthrits Rheum."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jcp.30529","article-title":"TGF-\u03b2 signaling: A recap of SMAD-independent and SMAD-dependent pathways","volume":"237","author":"Aashaq","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1074\/jbc.M115.694281","article-title":"Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-\u03b2 (TGF-\u03b2)\/Smad Signaling","volume":"291","author":"Yan","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Ungefroren, H. (2021). Autocrine TGF-\u03b2 in Cancer: Review of the Literature and Caveats in Experimental Analysis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020977"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.matbio.2011.03.005","article-title":"Early growth response transcription factors: Key mediators of fibrosis and novel targets for anti-fibrotic therapy","volume":"30","author":"Bhattacharyya","year":"2011","journal-title":"Matrix Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/art.24223","article-title":"Requirement of transforming growth factor beta-activated kinase 1 for transforming growth factor beta-induced alpha-smooth muscle actin expression and extracellular matrix contraction in fibroblasts","volume":"60","author":"Parapuram","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcdb.2019.11.013","article-title":"Non-canonical (non-SMAD2\/3) TGF-\u03b2 signaling in fibrosis: Mechanisms and targets","volume":"101","author":"Finnson","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/art.23634","article-title":"Molecular ablation of TGF-\u03b2 signaling pathways by tyrosine kinase inhibition: The coming of a promising new era in the treatment of tissue fibrosis","volume":"58","author":"Rosenbloom","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/art.30317","article-title":"Protein kinase C\u03b4 and c-Abl kinase are required for transforming growth factor \u03b2 induction of endothelial-mesenchymal transition in vitro","volume":"63","author":"Li","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bjd.12117","article-title":"Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis","volume":"168","author":"Yamaguchi","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"De Luca, G., Campochiaro, C., Burastero, S.E., Matucci-Cerinic, M., Doglioni, C., and Dagna, L. (2024). Periostin expression in uninvolved skin as a potential biomarker for rapid cutaneous progression in systemic sclerosis patients: A preliminary explorative study. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1214523"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jdermsci.2018.02.001","article-title":"Pro-fibrotic phenotype of human skin fibroblasts induced by periostin via modulating TGF-\u03b2 signaling","volume":"90","author":"Kanaoka","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jid.2022.12.008","article-title":"A Positive Loop Formed by SOX11 and Periostin Upregulates TGF-\u03b2 Signals Leading to Skin Fibrosis","volume":"143","author":"Nanri","year":"2023","journal-title":"J. Investig. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Park, H.N., Song, M.J., Choi, Y.E., Lee, D.H., Chung, J.H., and Lee, S.-T. (2023). LRG1 Promotes ECM Integrity by Activating the TGF-\u03b2 Signaling Pathway in Fibroblasts. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241512445"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e13556","DOI":"10.14814\/phy2.13556","article-title":"Leucine-rich \u03b1-2 glycoprotein promotes lung fibrosis by modulating TGF-\u03b2 signaling in fibroblasts","volume":"5","author":"Honda","year":"2017","journal-title":"Physiol. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.kint.2021.10.023","article-title":"Modulation of transforming growth factor-\u03b2-induced kidney fibrosis by leucine-rich \u237a-2 glycoprotein-1","volume":"101","author":"Hong","year":"2022","journal-title":"Kidney Int."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"B\u0103l\u0103nescu, P., B\u0103l\u0103nescu, E., B\u0103icu\u0219, C., and B\u0103l\u0103nescu, A. (2022). Circulatory cytokeratin 17, marginal zone B1 protein and leucine-rich \u03b12-glycoprotein-1 as biomarkers for disease severity and fibrosis in systemic sclerosis patients. Biochem. Med., 32.","DOI":"10.11613\/BM.2022.030707"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1083\/jcb.114.6.1285","article-title":"Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10","volume":"114","author":"Bradham","year":"1991","journal-title":"J. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1359-6101(97)00010-5","article-title":"Connective tissue growth factor: A mediator of TGF-beta action on fibroblasts","volume":"8","author":"Grotendorst","year":"1997","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.0022-202X.2003.22133.x","article-title":"Insights into the molecular mechanism of chronic fibrosis: The role of connective tissue growth factor in scleroderma","volume":"122","author":"Leask","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_70","first-page":"149","article-title":"Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: Association with extent of skin sclerosis and severity of pulmonary fibrosis","volume":"27","author":"Sato","year":"2000","journal-title":"J. Rheumatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/1523-1747.ep12318465","article-title":"Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis","volume":"105","author":"Igarashi","year":"1995","journal-title":"J. Investig. Dermatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"L603","DOI":"10.1152\/ajplung.00530.2007","article-title":"Proteomic analysis of CTGF-activated lung fibroblasts: Identification of IQGAP1 as a key player in lung fibroblast migration","volume":"295","author":"Bogatkevich","year":"2008","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Chen, Z., Zhang, N., Chu, H.Y., Yu, Y., Zhang, Z.K., Zhang, G., and Zhang, B.T. (2020). Connective Tissue Growth Factor: From Molecular Understandings to Drug Discovery. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.593269"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1139\/o03-069","article-title":"The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology","volume":"81","author":"Leask","year":"2003","journal-title":"Biochem Cell Biol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Tejera-Mu\u00f1oz, A., Marquez-Exposito, L., Tejedor-Santamar\u00eda, L., Rayego-Mateos, S., Orejudo, M., Suarez-\u00c1lvarez, B., L\u00f3pez-Larrea, C., Ru\u00edz-Ortega, M., and Rodrigues-D\u00edez, R.R. (2021). CCN2 Increases TGF-\u03b2 Receptor Type II Expression in Vascular Smooth Muscle Cells: Essential Role of CCN2 in the TGF-\u03b2 Pathway Regulation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010375"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1096\/fj.04-3217com","article-title":"Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation","volume":"19","author":"Grotendorst","year":"2005","journal-title":"FASEB J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s12079-021-00650-2","article-title":"The CCN2\/CTGF interactome: An approach to understanding the versatility of CCN2\/CTGF molecular activities","volume":"15","author":"Zaykov","year":"2021","journal-title":"J. Cell Commun. Signal."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"v2","DOI":"10.1093\/rheumatology\/ken265","article-title":"Role of PDGF in fibrotic diseases and systemic sclerosis","volume":"47","author":"Trojanowska","year":"2008","journal-title":"Rheumatology"},{"key":"ref_79","first-page":"1876","article-title":"Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma","volume":"22","author":"Ludwicka","year":"1995","journal-title":"J. Rheumatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1517\/14728222.2012.719500","article-title":"Targeting PDGF pathway in pulmonary arterial hypertension","volume":"16","author":"Antoniu","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory Autoantibodies to the PDGF Receptor in Systemic Sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.autrev.2007.02.020","article-title":"Stimulatory autoantibodies to the PDGF receptor: A link to fibrosis in scleroderma and a pathway for novel therapeutic targets","volume":"7","author":"Gabrielli","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Paolini, C., Agarbati, S., Benfaremo, D., Mozzicafreddo, M., Svegliati, S., and Moroncini, G. (2022). PDGF\/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073904"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jcp.1041330405","article-title":"Fibroblast growth factor: Structural and biological properties","volume":"133","author":"Gospodarowicz","year":"1987","journal-title":"J. Cell. Physiol. Suppl."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","article-title":"FGF\/FGFR signaling in health and disease","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_86","first-page":"90","article-title":"Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen \u03b1 2(I) gene expression in scleroderma and normal fibroblasts","volume":"24","author":"Ichiki","year":"1997","journal-title":"J. Rheumatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/path.4768","article-title":"Fibroblast growth factor-1 attenuates TGF-\u03b21-induced lung fibrosis","volume":"240","author":"Shimbori","year":"2016","journal-title":"J. Pathol."},{"key":"ref_88","first-page":"2","article-title":"Increased expression of basic fibroblast growth factor in skin of patients with systemic sclerosis","volume":"12","author":"Lawrence","year":"2006","journal-title":"Dermatol. Online J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0006-291X(89)92678-8","article-title":"Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells","volume":"161","author":"Ferrara","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1073\/pnas.86.19.7311","article-title":"Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells","volume":"86","author":"Gospodarowicz","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41580-023-00631-w","article-title":"Biology and therapeutic targeting of vascular endothelial growth factor A","volume":"24","author":"Ferrara","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_92","first-page":"1529","article-title":"Elevated vascular endothelial growth factor in systemic sclerosis","volume":"30","author":"Choi","year":"2003","journal-title":"J. Rheumatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","article-title":"Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis","volume":"95","author":"Distler","year":"2004","journal-title":"Circ. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1573397114666180809121005","article-title":"The Role of Vascular Endothelial Growth Factor in Systemic Sclerosis","volume":"15","author":"Flower","year":"2019","journal-title":"Curr. Rheumatol. Rev."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.rdc.2013.10.001","article-title":"Pulmonary arterial hypertension related to connective tissue disease: A review","volume":"40","author":"Ahmed","year":"2014","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Papaioannou, A.I., Zakynthinos, E., Kostikas, K., Kiropoulos, T., Koutsokera, A., Ziogas, A., Koutroumpas, A., Sakkas, L., Gourgoulianis, K.I., and Daniil, Z.D. (2009). Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis. BMC Pulm. Med., 9.","DOI":"10.1186\/1471-2466-9-18"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13075-015-0712-4","article-title":"Biomarkers of pulmonary hypertension in patients with scleroderma: A case\u2013control study","volume":"17","author":"McMahan","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","article-title":"Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis","volume":"109","author":"Manetti","year":"2011","journal-title":"Circ. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s12325-020-01581-x","article-title":"The Roles of Insulin-Like Growth Factor Binding Protein Family in Development and Diseases","volume":"38","author":"Song","year":"2021","journal-title":"Adv. Ther."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"101245","DOI":"10.1016\/j.molmet.2021.101245","article-title":"Insulin-like growth factors: Ligands, binding proteins, and receptors","volume":"52","author":"LeRoith","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.2353\/ajpath.2008.071021","article-title":"Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways","volume":"172","author":"Hsu","year":"2008","journal-title":"Am. J. Pathol."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Garrett, S.M., Hsu, E., Thomas, J.M., Pilewski, J.M., and Feghali-Bostwick, C. (2019). Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions. PLoS ONE., 14.","DOI":"10.1371\/journal.pone.0225422"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Waldrep, K.M., Rodgers, J.I., Garrett, S.M., Wolf, B.J., and Feghali-Bostwick, C.A. (2023). The Role of SOX9 in IGF-II-Mediated Pulmonary Fibrosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411234"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Chen, L., Song, B., Cui, Z., Chen, G., Yu, Z., and Song, B. (2022). Insulin-like Growth Factor-2 (IGF-2) in Fibrosis. Biomolecules, 12.","DOI":"10.3390\/biom12111557"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI200112347","article-title":"Role of protein kinase C-delta in the regulation of collagen gene expression in scleroderma fibroblasts","volume":"108","author":"Jimenez","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Wermuth, P.J., Addya, S., and Jimenez, S.A. (2011). Effect of protein kinase C delta (PKC-\u03b4) inhibition on the transcriptome of normal and systemic sclerosis human dermal fibroblasts in vitro. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027110"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1096\/fasebj.22.2_supplement.609","article-title":"Protein kinase C delta is necessary for the secretion of collagen type I from vascular smooth muscle cells","volume":"22","author":"Zohlman","year":"2008","journal-title":"FASEB J."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"F413","DOI":"10.1152\/ajprenal.00082.2003","article-title":"Smad3 and PKCdelta mediate TGF-beta1-induced collagen I expression in human mesangial cells","volume":"285","author":"Runyan","year":"2004","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/nar\/gki275","article-title":"Alpha2(I) collagen gene regulation by protein kinase C signaling in human dermal fibroblasts","volume":"33","author":"Jinnin","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"12232","DOI":"10.1074\/jbc.M112.428599","article-title":"PDZ-RhoGEF and LARG are essential for embryonic development and provide a link between thrombin and LPA receptors and Rho activation","volume":"288","author":"Mikelis","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.fob.2013.05.003","article-title":"Lysophosphatidylcholine enhances NGF-induced MAPK and Akt signals through the extracellular domain of TrkA in PC12 cells","volume":"3","author":"Wuhanqimuge","year":"2013","journal-title":"FEBS Open Bio"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/rheumatology\/keab762","article-title":"Serine\/threonine kinase inhibition as antifibrotic therapy: Transforming growth factor-\u03b2 and Rho kinase inhibitors","volume":"61","author":"Mendoza","year":"2022","journal-title":"Rheumatology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"168","DOI":"10.7150\/ijms.6.168","article-title":"Elevated serum levels of arachidonoyl-lysophosphatidic acid and sphingosine 1-phosphate in systemic sclerosis","volume":"6","author":"Tokumura","year":"2009","journal-title":"Int. J. Med. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1111\/bph.15190","article-title":"Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: From dermal fibroblasts of patients with scleroderma to tight skin 1 mouse","volume":"177","author":"Ledein","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1002\/art.39797","article-title":"An Autotaxin\/Lysophosphatidic Acid\/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis","volume":"68","author":"Castelino","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/art.40547","article-title":"Lysophosphatidic acid receptor 1 antagonist SAR100842 for patients with diffuse cutaneous systemic sclerosis: A double-blind, randomized, eight-week placebo-controlled study followed by a sixteen-week open-label extension study","volume":"70","author":"Allanore","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/art.42477","article-title":"A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis","volume":"75","author":"Khanna","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"240015","DOI":"10.1183\/16000617.0015-2024","article-title":"Lysophosphatidic acid receptor 1 inhibition: A potential treatment target for pulmonary fibrosis","volume":"33","author":"Volkmann","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"ref_119","unstructured":"(2025). A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis, ClinicalTrials.gov Identifier: NCT04781543 Accessed 8 September 2025."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Williams, T.M., and Lisanti, M.P. (2004). The caveolin proteins. Genome Biol., 5.","DOI":"10.1186\/gb-2004-5-3-214"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgab080","article-title":"Role of caveolin-1 in human organ function and disease: Friend or foe?","volume":"43","author":"Pang","year":"2022","journal-title":"Carcinogenesis"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.matbio.2013.03.005","article-title":"Role of caveolin-1 in fibrotic diseases","volume":"32","author":"Gvaramia","year":"2013","journal-title":"Matrix Biol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ncb975","article-title":"Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover","volume":"5","author":"Goodfellow","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/cr.2015.60","article-title":"Internalization of the TGF-\u03b2 type I receptor into caveolin-1 and EEA1 double-positive early endosomes","volume":"25","author":"He","year":"2015","journal-title":"Cell Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/art.23791","article-title":"Decreased expression of caveolin 1 in patients with systemic sclerosis: Crucial role in the pathogenesis of tissue fibrosis","volume":"58","author":"Sotgia","year":"2008","journal-title":"Arthritis Rheumatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/BOR.0b013e3283103d27","article-title":"Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis","volume":"20","author":"Lisanti","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/annrheumdis-2011-200986","article-title":"Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis","volume":"71","author":"Manetti","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ajpath.2012.10.022","article-title":"Caveolin-1 deficiency induces spontaneous endothelial-to-mesenchymal transition in murine pulmonary endothelial cells in vitro","volume":"182","author":"Li","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"L843","DOI":"10.1152\/ajplung.00295.2007","article-title":"Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo","volume":"294","author":"Tourkina","year":"2008","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Reese, C.F., Chinnakkannu, P., Tourkina, E., Hoffman, S., and Kuppuswamy, D. (2022). Multiple subregions within the caveolin-1 scaffolding domain inhibit fibrosis, microvascular leakage, and monocyte migration. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0264413"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Liu, J., Wang, F., and Luo, F. (2023). The Role of JAK\/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms. Biomolecules, 13.","DOI":"10.3390\/biom13010119"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1002\/art.34500","article-title":"JAK-2 as a novel mediator of the pro-fibrotic effects of transforming growth factor \u03b2 in systemic sclerosis","volume":"64","author":"Dees","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1111\/jdv.14876","article-title":"The use of JAK inhibitors in the treatment of progressive systemic sclerosis","volume":"32","author":"Deverapalli","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"103168","DOI":"10.1016\/j.autrev.2022.103168","article-title":"JAK inhibitors and systemic sclerosis: A systematic review of the literature","volume":"21","author":"Moriana","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10059-012-2297-y","article-title":"The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases","volume":"33","author":"Choi","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"102510","DOI":"10.1016\/j.jaut.2020.102510","article-title":"The roles of PPAR\u03b3 and its agonists in autoimmune diseases: A comprehensive review","volume":"113","author":"Liu","year":"2020","journal-title":"J. Autoimmun."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/art.20104","article-title":"Disruption of transforming growth factor beta signaling and pro-fibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma","volume":"50","author":"Ghosh","year":"2004","journal-title":"Arthritis Rheum."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bjps.2009.06.032","article-title":"Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts","volume":"63","author":"Zhang","year":"2010","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/art.24761","article-title":"Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis","volume":"60","author":"Kapoor","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Wei, J., Ghosh, A.K., Sargent, J.L., Komura, K., Wu, M., Huang, Q.Q., Jain, M., Whitfield, M.L., Feghali-Bostwick, C., and Varga, J. (2010). PPAR\u03b3 downregulation by TGF\u00df in fibroblast and impaired expression and function in systemic sclerosis: A novel mechanism for progressive fibrogenesis. PLoS ONE., 5.","DOI":"10.1371\/journal.pone.0013778"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/BOR.0b013e32833de1a7","article-title":"Peroxisome proliferator-activated receptor \u03b3 innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis","volume":"22","author":"Wei","year":"2010","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/ijd.15388","article-title":"Pharmacological activation of PPAR-\u03b3: A potential therapy for skin fibrosis","volume":"60","author":"Ghosh","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11926-012-0299-6","article-title":"Morphogen pathways in systemic sclerosis","volume":"15","author":"Beyer","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-012-1304-7","article-title":"Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis","volume":"305","author":"Beyer","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/BOR.0000000000000841","article-title":"The dynamic organelle primary cilia: Emerging roles in organ fibrosis","volume":"33","author":"Bhattacharyya","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/labinvest.2015.154","article-title":"Canonical Wnt signaling in systemic sclerosis","volume":"96","author":"Bergmann","year":"2016","journal-title":"Lab. Investig."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/med.21853","article-title":"The role of Wnt signaling in skin fibrosis","volume":"42","author":"Griffin","year":"2022","journal-title":"Med. Res. Rev."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Tinazzi, I., Mulipa, P., Colato, C., Abignano, G., Ballarin, A., Biasi, D., Emery, P., Ross, R.L., and Del Galdo, F. (2021). SFRP4 Expression Is Linked to Immune-Driven Fibrotic Conditions, Correlates with Skin and Lung Fibrosis in SSc and a Potential EMT Biomarker. J. Clin. Med., 10.","DOI":"10.3390\/jcm10245820"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/annrheumdis-2012-202544","article-title":"Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis","volume":"72","author":"Beyer","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/13543784.2020.1718105","article-title":"Targeting the Wnt signaling pathway: The challenge of reducing scarring without affecting repair","volume":"29","author":"Jarman","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/BOR.0000000000000110","article-title":"Emerging cellular and molecular targets in fibrosis: Implications for scleroderma pathogenesis and targeted therapy","volume":"26","author":"Castelino","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"dev186395","DOI":"10.1242\/dev.186395","article-title":"Circulating Hedgehog: A fresh view of a classic morphogen","volume":"147","author":"Prince","year":"2020","journal-title":"Development"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"jcs209742","DOI":"10.1242\/jcs.209742","article-title":"Functions of Wnt and Hedgehog-containing extracellular vesicles in development and disease","volume":"133","author":"Matusek","year":"2020","journal-title":"J. Cell Sci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41584-023-01032-1","article-title":"Back to the future: Targeting the extracellular matrix to treat systemic sclerosis","volume":"19","author":"Leask","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1002\/art.34444","article-title":"Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis","volume":"64","author":"Horn","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Effendi, W.I., and Nagano, T. (2021). The Hedgehog Signaling Pathway in Idiopathic Pulmonary Fibrosis: Resurrection Time. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010171"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41419-018-0692-9","article-title":"The hedgehog and Wnt\/\u03b2-catenin system machinery mediate myofibroblast differentiation of LR-MSCs in pulmonary fibrogenesis","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/1756-185X.13247","article-title":"Anti-fibrotic effects of pirfenidone by interference with the hedgehog signalling pathway in patients with systemic sclerosis-associated interstitial lung disease","volume":"21","author":"Xiao","year":"2018","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Lui, P.P., Xu, J.Z., Aziz, H., Sen, M., and Ali, N. (2024). Jagged-1+ skin Tregs modulate cutaneous wound healing. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-71512-1"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/ard.2010.134742","article-title":"Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis","volume":"70","author":"Dees","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Condorelli, A.G., El Hachem, M., Zambruno, G., Nystrom, A., Candi, E., and Castiglia, D. (2021). Notch-ing up knowledge on molecular mechanisms of skin fibrosis: Focus on the multifaceted Notch signalling pathway. J. Biomed. Sci., 28.","DOI":"10.1186\/s12929-021-00732-8"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/1744666X.2021.2000391","article-title":"The role of the Notch pathway in the pathogenesis of systemic sclerosis: Clinical implications","volume":"17","year":"2021","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5021\/ad.2019.31.4.365","article-title":"The Significance of NOTCH Pathway in the Development of Fibrosis in Systemic Sclerosis","volume":"31","author":"Styk","year":"2019","journal-title":"Ann. Dermatol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/19\/9596\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:12:40Z","timestamp":1759317160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/19\/9596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":164,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["ijms26199596"],"URL":"https:\/\/doi.org\/10.3390\/ijms26199596","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}